Atlas FDA

Juvederm Injectable Gel Implants

FDA premarket approval P110033/S046 · decided 2019-06-26

Approval details

PMA number
P110033
Supplement
S046
Supplement type
Special (Immediate Track)
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Juvederm Injectable Gel Implants
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2019-05-28
Decision date
2019-06-26
Days to decision
29 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
Approval for inclusion of an additional inspection step to the current manual inspection method during the manufacturing process for the Juvederm Injectable Gel Implants.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25